Feels like a game of snakes and ladders! Well if repricing over next week gets us into the 500s, that might be enough for the 250, here’s hoping. |
On the subject of MSCI rebalancing I was sent this by a market professional in relation to another stock- I assume it applies here as well.
“The pricing period will be any of the last 10 days of October (18-31 October), with a very heavy bias to the first few days. The announcement of changes will be made on 07 November with rebalance on close 26 November.” |
2 thread merit marks to chillpill for remembering that one.
For those wondering, see this link (page 6)
Which was notification of us being removed from that index back in Nov 2023 because our market cap had dropped too low.
Definitely something to keep an eye on / bear in mind to help explain today as if we were booted out c200p last year, then every chance of the reverse manoeuvre this year at c400p.
Could easily have been some anticipation of that today. |
Hopefully back in the MSCI this time and FTSE 250 next quarter. |
Wall Street opening often sees a tick up for OXB it seems. |
Tick up in volume and firming of price pre and post Wall St opening.Could be relevant. |
If it holds this until close it will be back to where we were on close of Aug 3rd 2023 before the sky fell in.
No complaints from me but currently no obvious trigger for the bounce back today. |
heavy trading today it seems ... |
We're still living with the hangover of the vaccine work ending, losing Homology as a big customer and OXB resetting the earnings guidance about 13 months ago.
I'm sure that still has a lot of people cautious.
Without that worry OXB should never have dropped much below a fiver in 2023. Should have been c£7 for most of this year on the back of C£130m guidance and a tenner as we go into next year.
Unfortunately people remember these stories even if they don't currently follow OXB and of course we have had analysts like Numis doubting OXB's forecasts in the Times.
This is basically the root of my longstanding hope that zero OXB insiders buying means they have something good to announce at some point. Lucky timing with that and it could be all past sins forgiven. |
Nice rise today shame my Cambridge Cognition shares can't do the same.
Hopefully OXB reaches a fiver by the end of the year. |
Like a stopped clock |
Redirish
I understand you completely
I cancelled my stocko a few years ago.
I couldn’t see how it was able to have an accurate view/prediction on every listed company…I guess it’s accurate sometimes |
Harry - got you. |
I've just renewed my Stockopeadia subscription for the year. It continues to tell me that OXB, my largest holding, is a momentum trap. I continue to ignore it. And yet I paid..... |
I'd love to know wtf is goin' on 'ere |
takeiteasy,
I was just clarifying that I didn't ever say forced selling from £15. |
If you look at the free order book snapshot ( click the "today" bar on the chart and scroll to the bottom of the page) the numbers there at the moment are c60p better than Friday on no public news.
Maybe this is all down to that tip generating website, but surely something else here which we just don't know about yet? |
Harry, I know what has happened - the analysts covering the stock have appended your posts to their client research emails and said words to the effect "if you don't believe our work, believe in Harry a trusted voice on ADVFN" ...:) |
Yes indeed,a 325th qualifying position would currently require a market cap of well over £500m.I've had my doubts whether inclusion would occur in 2024 but i'm happy to be proved wrong. |
 takeiteasy,
I don't mind the moaning part, but the forced selling is from 1st August last year (allegedly) and if you look at that short position chart and compare it with the posting on badger's thread of truth, it does all support the theory that people had worked out one US fund was very near having to sell if OXB dropped below it's market cap size rules for core holdings. I think the second fund triggered by that at a lower level was just a bonus. It must have made some people a lot of money.
But my point here is that's basically a drop from a steady trend of 400 to 500p which would have been about right for the work (revenue) OXB had after the vaccine contract suddenly halted (i.e. 90m x 5.5 for a market cap). £15 was covid mania and the drop from that was like any bubble bursting imho and nothing to do with forced selling.
I'm much more interested now in the future, the very real possibility of c£180m in sales next year supporting a very sensible £10 share price.
As for what's happening today? No idea. |
M, if the traders here were sneaky they would push up the share price in a way to "encourage" the board to explain a share price rise...i.e. tease some news out of them :) |
About 527p last Friday SJ
What it will be at close 24 working days from now of course depends on the index. |
There's the RNS but not the one that will truly propel the price to the moon |
As much as we would like rational explanations for share price movements,the volatility amongst second line stocks can often be near unfathomable nowadays.Something around 480p would make OXB a FT250 contender and invariably stocks move ahead sharply in anticipation of inclusion.As Dominic C.mentioned awhile back,it has felt like there's a large buyer about and that sharp move down in the price last week to around 360p ish felt like a tree shake,a throw of the dice to shake out loose holders. |
Hopefully now a competition where everyone needs some and will keep buying while it keeps rising...FOMO |
Register for real-time alerts, custom portfolio, and market movers
Hot Features
Premium
